CD160% expression was positive in 90% of CLL patients versus 60% of B-NHL and 60% of HCL patients, thus showing a statistical significance in B-NHL patients (p=0.009) and no statistical significant difference was found with HCL (p=0.139) (Table 2, Fig.1A). The gene discussed is CD160; the disease is B-cell chronic lymphocytic leukemia.